Home›Research›Compare›Argireline vs BPC-157
Peptide Comparison
Argireline vs BPC-157
Argireline
Acetyl Hexapeptide-3
Half-life: N/A (topical)
18 providers listed
BPC-157
Body Protection Compound 157
Half-life: 4–6 hours (subcutaneous); 1–2 hours (oral)
592 providers listed
Quick Verdict
Argireline
Risk
Half-life
N/A (topical)
BPC-157
Risk
Half-life
4–6 hours (subcutaneous); 1–2 hours (oral)
Side-by-Side Comparison
About Argireline
Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects
A topical peptide that reduces the appearance of expression lines by mimicking botulinum toxin's mechanism locally. Popular cosmeceutical ingredient.
Research Areas
About BPC-157
BPC-157 is believed to accelerate angiogenesis and upregulate growth hormone receptors locally at injury sites. It appears to promote fibroblast migration and collagen synthesis, contributing to faster tissue remodelling. Animal studies suggest systemic effects via modulation of the dopaminergic and serotonergic systems, though human data remain limited.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It is commonly researched for its role in soft tissue repair, particularly in tendons, ligaments, and muscle following injury or high training loads. Early research suggests it may also support gut integrity and systemic healing.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Argireline
18 listed
Browse directory →
Providers offering
BPC-157
592 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.